Accepting applications until August 1
Accepting applications until August 1
Wenhui Ren 1, Xiangyu Guo 2, Zheng Liu, et al. Cancer 2025 Jan 15;131(2):e35712
Breast cancer and reproductive system cancers remain significant public health threats for Chinese women. In 2021, China reported 385.84 thousand incident cases of female breast cancer, followed by cervical cancer, uterine cancer,... Read More
Yujie Wu, Siyi He, Mengdi Cao,et al. Chin Med J (Engl) 2024 Dec 20;137(24):3093-3100
https://doi.org/10.1016/j.jncc.2024.06.005 In 2024, there are an estimated 3,246,625 and 2,510,597 new cancer cases and 1,699,066 and 640,038 cancer deaths in China and the US, respectively. The highest estimated cancer cases are... Read More
Hongmei Zeng, Rongshou Zheng, Kexin Sun et al. J Natl Cancer Cent. 2024 Jun 22;4(3):203-213
A milestone goal of the Healthy China Program (2019-2030) is to achieve 5-year cancer survival at 43.3% for all cancers combined by 2022. To assess the progress towards this target, we analyzed the updated survival for all cancers... Read More
Bingfeng Han 1, Rongshou Zheng 1, Hongmei Zeng 1, et al. J Natl Cancer Cent. 2024 Feb 2;4(1):47-53
The National Cancer Center (NCC) of China regularly reports the nationwide statistics on cancer incidence and mortality in China. The International Agency for Research on Cancer (IARC) calculates and publishes the cancer burden of... Read More
Edward Christopher Dee, Mathieu Laversanne, Nirmala Bhoo-Pathy Lancet Oncol. 2025 Apr;26(4):516-528
Cancer is a leading cause of morbidity and mortality in southeast Asia. We aimed to present and interpret cancer incidence and mortality statistics in the 11 constituent countries of Brunei, Cambodia, Indonesia, Laos, Malaysia, My... Read More
GBD 2023 Breast Cancer. The Lancet Oncology. 2026. 27:302-326
In 2023, there were an estimated 2·30 million breast cancer incident cases, 764 000 deaths , and 24·1 million DALYs among females globally. The age-standardised incidence rate (ASIR) was the highest (24·1 per 100 000 [16·8 to 31·9... Read More
Youao Zhang, Pinhao Wang, Zixuan Jia,et al. Sci Rep. 2025 Feb 11;15(1):5123
Male cancers, which refers to cancers that occur exclusively in males, is a prevalent type of cancer worldwide, primarily including prostate cancer (PCa) and testicular cancer (TCa). These cancers are significant contributors to t... Read More
Habtamu Mellie Bizuayehu, Abel F Dadi, Kedir Y Ahmed Cancer 2024 Nov 1;130(21):3708-3723
Men exhibit higher prevalence of modifiable risk factors, such as smoking and alcohol consumption, leading to greater cancer incidence and lower survival rates. The authors analyzed 30 cancer types among men in 2022, with projecti... Read More
Yingying Li, Wenfu Song, Ping Gao, et al. BMC Cancer (2025) 25:330
Female breast cancer, cervical cancer, uterine cancer, and ovarian cancer (FBCUO) pose a significant threat to global public health. Data from the Global Burden of Disease, Injuries, and Risk Factors Study (GBD) 2021 provide criti... Read More
Wei Cao 1, Kang Qin 2, Feng Li 3, Wanqing Chen J Natl Cancer Cent. 2024 May 7;4(2):128-134
The International Agency for Research on Cancer (IARC) released the latest estimates of the global burden of cancer. We present a comparison of cancer profiles between 2020 and 2022, leveraging data from the Global Cancer Statisti... Read More
Zenghong Wu, Fangnan Xia and Rong Li. Journal of Hematology & Oncology, (2024)
Cancer is the second most common cause of death globally.This study aimed to assess cancer burden and associated risk factors in 204 countries and territories between 1980 and 2021.Methods We selected data on cancer incidence and... Read More
Habtamu Mellie Bizuayehu, PhD, MPH; Kedir Y. Ahmed, PhD; Getiye Dejenu Kibret, P JAMA
Cancer prevention and care efforts have been challenged by the COVID-19 pandemicand armed conflicts, resulting in a decline in the global Human Development Index (HDI), particularly in low- and middle-income countries. This popula... Read More